Close menu




January 24th, 2020 | 14:11 CET

Beyond Meat, Burcon NutraScience, Nestle - scalable growth with plant proteins

  • Food
Photo credits: pixabay.com

Humanity is always striving for improvement. This has not only been the case since the climate debate, but innovations in all areas of everyday life are constantly changing our lives. The changes will never again be as slow as they are at this moment. Research and development solve problems or create new needs. In the ideal case even both. Nutritious and tasty food with an improved CO2 footprint is on the agenda of food producers like Beyond Meat and Nestle. But developing innovation costs not only money, but also time. The latter usually leads to partnerships or even takeovers.

time to read: 1 minutes | Author: Mario Hose
ISIN: CA1208311029 , US08862E1091 , CH0038863350

Table of contents:


    Pay for 20 years' work

    Burcon NutraScience from Canada has been working for 20 years on the development of plant proteins. As was announced today, the company has entered into a comprehensive partnership with one of the world's largest food companies.

    The partnership combines Nestle's expertise in the development, production and marketing of plant foods and beverages with Burcon's proprietary technology for the extraction and purification of plant proteins, while leveraging Burcon's JV partner Merit Food's state-of-the-art plant protein production facilities in Manitoba, Canada. The joint venture with production company Merit was only established in May 2019.

    Stefan Palzer, Nestle's Chief Technology Officer, explains the collaboration in the company's announcement: 'The partnership with Burcon and Merit will give us access to unique expertise and a new range of high-quality ingredients for plant-based food and beverages.'

    Meat substitute from the plant world

    The partnership with Nestle validates the expertise Burcon NutraScience has built over more than 20 years of research and development. The company now holds more than 270 patents relating to plant proteins, with a further 260 applications pending.

    Burcon NutraScience will be the first company in the world to combine canola and pea proteins. The mixed protein, called Nutratein, has the same amino acid profile as meat. The solubility of Burcon's proteins means that they can also be used in beverages and non-dairy products, another market with enormous potential.

    Beyond Meat gets competition

    In today's announcement, Nestle mentions that the company already has a vegetable product range consisting of pea, soya and wheat burgers, sausages, minced meat, chicken fillets and various other convenience foods. In addition, the company is also working on plant-based milk alternatives and milk-free ice creams.

    This new partnership between Burcon NutraScience and Nestle gives Beyond Meat a serious competitor. At the end of the day, the trend toward climate protection is moving in the right direction with increasing competition. For Burcon NutraScience the framework for scalable growth is now in place.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Mario Hose

    Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

    About the author



    Related comments:

    Commented by Fabian Lorenz on August 20th, 2026 | 07:35 CEST

    Insider Alert, Shock and Opportunity in These Stocks: HelloFresh, Steyr Motors and Standard Uranium

    • Uranium
    • nuclear
    • decarbonization
    • Automotive
    • Food

    Alarm bells are ringing at HelloFresh. The stock has lost 50% so far this year. Fewer customers are placing orders, and earnings are deep in the red. Is there still hope? From the board's perspective, apparently not—the CEO has been selling shares. At Standard Uranium, on the other hand, a strategic investor has come on board—and for good reason. The uranium market is poised for strong growth, while Standard Uranium has once again reported strong drilling results. The stock is still lagging behind this trend—for now. Steyr Motors, meanwhile, has shocked its shareholders. After takeover speculation had already quickly evaporated, the company hit investors with another surprise this week in the form of a profit warning. Orders from the defense sector are proving to be both a blessing and a curse. Is now the time to buy?

    Read

    Commented by Carsten Mainitz on August 19th, 2026 | 07:55 CEST

    Weight-Loss Boom 2.0: BioNxt Solutions, Novo Nordisk and Nestlé Are Growing in a Billion-Dollar Market

    • Biotech
    • Obesity
    • Pharma
    • weightloss
    • Food

    The weight-loss injection has not only transformed the pharmaceutical market but is also gradually impacting the food industry. The prescription drug semaglutide, used to treat type 2 diabetes and obesity, is at the forefront of this trend. The active ingredient mimics the body's own gut hormone GLP-1, thereby achieving several desired effects. It increases feelings of fullness, reduces appetite, slows gastric emptying, and improves insulin secretion. Meanwhile, innovative specialists such as BioNxt Solutions are positioning themselves by advancing alternative and improved drug delivery methods. The Canadian company is developing thin films of active ingredients that dissolve under the tongue and are intended to replace medications administered via injection or traditional tablets. The news flow is promising. At the same time, Nestlé is creating a new food category for people who want to lose weight using GLP-1 preparations. Who has the edge?

    Read

    Commented by Jens Castner on August 12th, 2026 | 07:30 CEST

    Buckle Up for a Short Squeeze: Could Almonty and HelloFresh Follow SpaceX's Rocket Launch?

    • Tungsten
    • Defense
    • aerospace
    • hightech
    • Food
    • foodtech
    • shortsqueeze

    When short sellers are caught off guard, it can lead to veritable price explosions. Although no supernova was observed at the aerospace company SpaceX last week, it was definitely more than a gentle liftoff: the share price shot up by more than 15% following its quarterly results. Notably high short positions have also recently built up for the tungsten producer Almonty Industries and the meal-kit delivery service HelloFresh. With earnings reports just around the corner for both stocks, these numbers could become the catalyst for an even bigger move.

    Read